Drug profile · INN
efungumab
MYCOGRAB
efungumab (MYCOGRAB) is a heat shock protein 90 homolog inhibitor.
EMA: refused Antiinfectives for systemic use (J02) J02
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — efungumab
- Class
- Antiinfectives for systemic use (J02)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
efungumab (MYCOGRAB) is a heat shock protein 90 homolog inhibitor.
Key facts
INN efungumab
Brand MYCOGRAB
Mechanism Heat shock protein 90 homolog inhibitor
Target Heat shock protein 90 homolog
Therapeutic class Antiinfectives for systemic use (J02)
ATC code J02
Mechanism of action
Heat shock protein 90 homolog inhibitor
Primary target: Heat shock protein 90 homolog
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | refused | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is efungumab?
efungumab (MYCOGRAB) is a heat shock protein 90 homolog inhibitor.
What is the brand name for efungumab?
MYCOGRAB is a marketed brand name for efungumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.